Thrombus in the heart is known to be one of the many sequelae of anterior wall myocardial infarction, atrial fibrillation and coagulation disorders. However, biventricular thrombi are relatively rarely found, even in conditions with a high possibility of thrombus formation. We report the case of a 75-year-old-woman with newly diagnosed systolic heart failure secondary to a nonischemic cardiomyopathy, who was found to have large biventricular thrombi. Further coagulopathy work-up revealed that she was heterozygous for the prothrombin 20210G/A and homozygous for the methylenetetrahydrofolate reductase (MTHFR) 677C/T mutations. We, herein, review and discuss previous case reports and published literature regarding ventricular thrombosis and its treatment. To the best of our knowledge, this is the first case of biventricular thrombosis with prothrombin 20210G/A and MTHFR 677C/T mutations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjms.2017.10.005DOI Listing

Publication Analysis

Top Keywords

biventricular thrombi
12
prothrombin 20210g/a
12
677c/t mutations
12
heart failure
8
heterozygous prothrombin
8
20210g/a homozygous
8
homozygous methylenetetrahydrofolate
8
methylenetetrahydrofolate reductase
8
mthfr 677c/t
8
biventricular
4

Similar Publications

Background: Fulminant eosinophilic myocarditis (EM) is a rare and often fatal condition that may present atypically and be complicated by ventricular arrhythmias. Treatment involves high-dose corticosteroids to suppress eosinophilia, as well as increasing use of mepolizumab, an anti-interleukin-5 antibody with evidence for long-term efficacy and safety.

Case Summary: A 38-year-old woman presented to the emergency department with neck pain and fatigue, and after extensive investigation was diagnosed with EM secondary to idiopathic hypereosinophilic syndrome.

View Article and Find Full Text PDF
Article Synopsis
  • Pump thrombosis is a serious complication after getting a left ventricular assist device (LVAD) that can increase health risks and affect eligibility for heart transplantation.
  • A case report highlights a new method using temporary, less invasive biventricular devices to support a patient with heart failure caused by LVAD thrombosis.
  • This innovative approach may provide effective heart support while keeping patients mobile, which could improve their chances of successfully getting a heart transplant.
View Article and Find Full Text PDF

Over the previous 20 years, the use of extracorporeal membranous oxygenation (ECMO) as a bridge to durable left ventricular assist device (dLVAD) increased significantly. Additionally, emerging literature has demonstrated a protective effect of biventricular decompression while on ECMO, with one such strategy including a temporary LVAD and right ventricular assist device (RVAD). The complexity of these operations is increased by the frequency of re-sternotomies, which result in adhesions and difficult access to traditional cannulation sites.

View Article and Find Full Text PDF

Anesthetic Management for Aspiration Thrombectomy Using the Penumbra Indigo System in Pediatric Patients with Congenital Heart Disease.

J Cardiothorac Vasc Anesth

November 2024

Department of Anesthesia, Harvard Medical School, Boston, MA; Division of Cardiac Anesthesia, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA. Electronic address:

Objective: To describe clinical characteristics and outcomes, including transfusion requirements, in pediatric patients with congenital heart disease undergoing aspiration thrombectomy.

Design: Retrospective chart review.

Setting: Quaternary academic children's hospital.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!